Sign in

CIK 0001061983

  • Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
943291317
Phone
+1 650-624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,320,469
in 18 filings, $12.5M under 10b5-1 plans

Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-06 Malik Fady Ibraham EVP Research & Development Shares withheld for taxes −8,109 $66.88 $542K 121,234
2024-03-06 Blum Robert I President & CEO Shares withheld for taxes −16,725 $66.88 $1.1M 399,731
2024-03-06 Callos Andrew EVP, Chief Commercial Officer Shares withheld for taxes −5,103 $66.88 $341K 46,946
2024-03-05 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −4,000 $67.53 $270K 138,973
2024-03-05 Malik Fady Ibraham EVP Research & Development Exercise or conversion 10b5-1 +28,604 $6.67 $191K 167,577
2024-03-05 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −28,604 $67.56 $1.9M 138,973
2024-03-05 Malik Fady Ibraham EVP Research & Development Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −28,604 28,605
2024-03-04 Wong Robert VP, Chief Accounting Officer Shares withheld for taxes −1,783 $67.68 $121K 26,442
2024-03-04 Malik Fady Ibraham EVP Research & Development Shares withheld for taxes −9,630 $67.68 $652K 133,343
2024-03-04 Blum Robert I President & CEO Shares withheld for taxes −25,341 $67.68 $1.7M 416,456
2024-03-04 Callos Andrew EVP, Chief Commercial Officer Shares withheld for taxes −2,202 $67.68 $149K 52,049
2024-02-14 HENDERSON JOHN T Director Exercise or conversion 10b5-1 +5,000 $4.44 $22K 47,632
2024-02-14 HENDERSON JOHN T Director Sale 10b5-1 −5,000 $76.48 $382K 42,632
2024-02-14 HENDERSON JOHN T Director Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −5,000 0
2024-02-13 Blum Robert I President & CEO Exercise or conversion 10b5-1 +12,500 $6.67 $83K 454,297
2024-02-13 Blum Robert I President & CEO Sale 10b5-1 −12,500 $76.85 $961K 441,797
2024-02-13 Blum Robert I President & CEO Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 118,494
2024-02-06 Malik Fady Ibraham EVP Research & Development Exercise or conversion 10b5-1 +28,605 $6.67 $191K 175,578
2024-02-06 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −28,605 $79.30 $2.3M 146,973
2024-02-06 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −4,000 $79.28 $317K 142,973

Page 35 of 45 · 885 trades